DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Acquired by LPL Financial LLC

LPL Financial LLC boosted its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 52.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 115,108 shares of the medical instruments supplier’s stock after purchasing an additional 39,498 shares during the quarter. LPL Financial LLC owned about 0.06% of DENTSPLY SIRONA worth $2,185,000 as of its most recent filing with the SEC.

Other institutional investors also recently made changes to their positions in the company. Pacer Advisors Inc. increased its position in shares of DENTSPLY SIRONA by 15,105.1% during the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock worth $85,478,000 after acquiring an additional 4,473,972 shares during the last quarter. Cooke & Bieler LP increased its holdings in DENTSPLY SIRONA by 24.3% during the 4th quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier’s stock worth $174,101,000 after purchasing an additional 1,794,391 shares during the last quarter. JPMorgan Chase & Co. increased its stake in shares of DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock worth $49,990,000 after buying an additional 1,244,326 shares during the last quarter. American Century Companies Inc. grew its holdings in DENTSPLY SIRONA by 38.2% during the 4th quarter. American Century Companies Inc. now owns 3,873,645 shares of the medical instruments supplier’s stock worth $73,522,000 after acquiring an additional 1,071,604 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in shares of DENTSPLY SIRONA in the 4th quarter valued at about $10,335,000. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Price Performance

NASDAQ:XRAY opened at $13.08 on Tuesday. DENTSPLY SIRONA Inc. has a 52-week low of $12.16 and a 52-week high of $31.75. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The stock’s 50-day simple moving average is $16.09 and its 200 day simple moving average is $19.01. The company has a market cap of $2.60 billion, a P/E ratio of -6.32, a P/E/G ratio of 1.80 and a beta of 0.92.

DENTSPLY SIRONA Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were paid a $0.16 dividend. The ex-dividend date of this dividend was Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a yield of 4.89%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -14.07%.

Insider Buying and Selling at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier acquired 15,142 shares of the business’s stock in a transaction that occurred on Monday, March 3rd. The stock was acquired at an average price of $16.51 per share, with a total value of $249,994.42. Following the completion of the transaction, the director now directly owns 81,971 shares of the company’s stock, valued at $1,353,341.21. This trade represents a 22.66 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.52% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on XRAY. Needham & Company LLC reiterated a “hold” rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. StockNews.com cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Robert W. Baird cut their target price on DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research report on Friday, February 28th. Morgan Stanley cut their price target on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a report on Tuesday, December 17th. Finally, Mizuho decreased their price target on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating on the stock in a research report on Thursday, March 13th. Twelve investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $23.33.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.